MTRC has released 8 European reimbursement reports for radiotherapy

11

Apr 2018

MTRC, a leading Med Tech reimbursement consultancy in Europe, has developed 8 reimbursement reports with a total size of 882 pages for the most common radiotherapy modalities in 12 European countries: Austria, Belgium, Denmark, Finland, England, France, Germany, Italy, the Netherlands, Norway, Sweden, and Switzerland.

There are eight reports available for:

Each report includes essential reimbursement information: procedure coding, payment mechanism, reimbursement tariffs and policy considerations. Reports are developed using official reimbursement information and series of interviews with practicing radiologists. You can learn more and request sample pages at our website http://www.mtrconsult.com/repository-of-reports

The price of the first report is 11,500 euros. The prices for subsequent reports are progressively decreasing.

Contact us, if you would like to discuss the methodology and the content of the reports with our experts.

The latest related news

13

May 2021

At the beginning of April 2021, the Ministry of Health of the Russian Federation released the final report on key results of 2020 and main targets for 2021. One of the key achievements is the increased number of medical organizations licensed to conduct high-end medical care (reached 629, including 141 federal centers).

Read more

11

May 2021

In late April and early May 2021, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, fifteen health apps are now available at the DiGA Directory.

Read more

05

May 2021

Transcatheter aortic valve implantation (TAVI/TAVR) in severe aortic stenosis treatment across all surgical risk groups was being evaluated within the "New Methods" framework since 2019. On April 26, 2021, the Decision Forum for "New Methods" made a positive coverage decision for TAVI/TAVR to treat patients with severe aortic stenosis across all surgical risk groups.

Read more

04

May 2021

In April 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0176 and 0073 with changes to be implemented not later than August 01, 2021. Four new procedure codes related to men's health and breast surgery and one new companion diagnostic code were introduced.

Read more

03

May 2021

On April 22, 2021, the List of reimbursable implants and invasive medical devices, maintained by the National Institute for Health and Disability Insurance (INAMI), was updated with the corresponding Nominative lists of brand-specific devices. Two new Nominative lists with reimbursable devices used for peripheral vascular interventions were introduced.

Read more